Cancer Biotechnology (CB)

Overview: 
Recent biotechnology advances have facilitated the need to educate NIH fellows in new methodology. The Cancer Biotechnology (CB) course will be held at Frederick National Lab on February 10, February 24, and March 9, 2012 in Bldg. 549 (Conference Center). The topics covered include: proteomics, protein expression, genomics, image analysis, drug discovery, nanotechnology and bioinformatics. The participation of NIH postdoctoral fellows who want to learn about new biotechnology advances is encouraged.

Links and Related Training Opportunities. 
This course is part of a developing curriculum for training of NCI clinical and postdoctoral fellows. Each Fall, a course in "Translational Research in Clinical Oncology" and "Redox Biology" is offered primarily for NIH postdoctoral fellows. In January, a 2-day course is offered on the "Statistical Analysis of Research Data" hosted by Dr. T. Moody which is offered for NIH clinical and postdoctoral fellows. For additional opportunities for postdoctoral training at NIH view http://www.training.nih.gov/.

Registration
The deadline for registration is February 8, 2012. The first 50 registrants will be accepted for the class. Registration, at no charge, is available online at http://ccr.cancer.gov/careers/courses/cb/registration/form.asp. The course will be hosted by Dr. Terry Moody, Tel: 301.451.9451.

Transportation: 
The course will be based at Frederick National Lab.  Registrants can drive their own automobile or ride in the NCI-Frederick van, which departs from Bldg. 10 (South entrance) in Bethesda at 10:55 a.m.  The van arrives in Frederick at 11:45 a.m. at Bldg. 426.  The van leaves Frederick at 3:30 p.m. (Bldg. 426) and returns to Bethesda at 4:30 p.m.